Plasma YKL-40 levels in healthy subjects from the general population

Stig E Bojesen; Julia S Johansen; Børge G Nordestgaard

doi:10.1016/j.cca.2011.01.022

Plasma YKL-40 levels in healthy subjects from the general population

Stig E Bojesen, Julia S Johansen, Børge G Nordestgaard

Afdeling for Kræftbehandling HGH

117 Citationer (Scopus)

Abstract

Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects.

Originalsprog	Engelsk
Tidsskrift	Clinica chimica acta; international journal of clinical chemistry
Vol/bind	412
Udgave nummer	9-10
Sider (fra-til)	709-12
Antal sider	4
DOI	https://doi.org/10.1016/j.cca.2011.01.022
Status	Udgivet - 11 apr. 2011

Adgang til dokumentet

10.1016/j.cca.2011.01.022

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{6fb06231738b416680def05e78531076,

title = "Plasma YKL-40 levels in healthy subjects from the general population",

abstract = "Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects.",

author = "Bojesen, \{Stig E\} and Johansen, \{Julia S\} and Nordestgaard, \{B{\o}rge G\}",

year = "2011",

month = apr,

day = "11",

doi = "10.1016/j.cca.2011.01.022",

language = "English",

volume = "412",

pages = "709--12",

journal = "Clinica chimica acta; international journal of clinical chemistry",

issn = "1873-3492",

publisher = "Elsevier BV",

number = "9-10",

}

TY - JOUR

T1 - Plasma YKL-40 levels in healthy subjects from the general population

AU - Bojesen, Stig E

AU - Johansen, Julia S

AU - Nordestgaard, Børge G

PY - 2011/4/11

Y1 - 2011/4/11

N2 - Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects.

AB - Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects.

UR - https://www.scopus.com/pages/publications/79951726251

U2 - 10.1016/j.cca.2011.01.022

DO - 10.1016/j.cca.2011.01.022

M3 - Journal article

C2 - 21272568

SN - 1873-3492

VL - 412

SP - 709

EP - 712

JO - Clinica chimica acta; international journal of clinical chemistry

JF - Clinica chimica acta; international journal of clinical chemistry

IS - 9-10

ER -

Plasma YKL-40 levels in healthy subjects from the general population

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater